Julie Waras Brogren
Financieel Directeur/CFO bij ASCELIA PHARMA AB
Vermogen: 59 016 $ op 31-05-2024
Profiel
Julie Waras Brogren is currently the Deputy CEO-Finance & Investor Relations at Ascelia Pharma AB.
She is also a Director at Ossiform ApS and Pila Pharma AB.
Previously, she worked as a Senior Director-Launch Office at Novo Nordisk A and as the President of Bresotec, Inc. from 2017 to 2019.
Ms. Brogren holds a graduate degree from Copenhagen Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASCELIA PHARMA AB
0.17% | 13-07-2023 | 59 000 ( 0.17% ) | 59 016 $ | 31-05-2024 |
Actieve functies van Julie Waras Brogren
| Bedrijven | Functie | Begin |
|---|---|---|
| ASCELIA PHARMA AB | Financieel Directeur/CFO | 01-01-2023 |
| PILA PHARMA AB | Directeur/Bestuurslid | 01-04-2024 |
Ossiform ApS
 Ossiform ApS Miscellaneous Commercial ServicesCommercial Services Ossiform ApS offers technology for 3D print patient fitted bone implants. The company was founded by Casper Slots, Martin Bonde Jensen, Morten Østergaard Andersen, and Torben Henrik Thygesen in 2017 and is headquartered in Odense, Denmark. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Julie Waras Brogren
| Bedrijven | Functie | Einde |
|---|---|---|
| Bresotec, Inc. | President | 01-06-2019 |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Opleiding van Julie Waras Brogren
| Copenhagen Business School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ASCELIA PHARMA AB | Health Technology |
| NOVO NORDISK A/S | Health Technology |
| PILA PHARMA AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Ossiform ApS
Ossiform ApS Miscellaneous Commercial ServicesCommercial Services Ossiform ApS offers technology for 3D print patient fitted bone implants. The company was founded by Casper Slots, Martin Bonde Jensen, Morten Østergaard Andersen, and Torben Henrik Thygesen in 2017 and is headquartered in Odense, Denmark. | Commercial Services |
| Bresotec, Inc. |
